Christina Lockhart

Director Clinical Operations

With over 18 years’ working in pharma, biotech, CROs, and research centers, Christina brings a wealth of experience including management and monitoring of Phase 1 through Phase 4 pharmaceutical, biologic, device, and tobacco studies. After leaving an orthopaedic research site, she has focused primarily on rare-disease and novel therapy study management.

Christina has developed study management tools, processes and procedures that facilitate operations from study conception to study close-out. Prior to joining Aceragen, Christina spear-headed a COVID-19 treatment trial with the focus on rapid study take-off. After completing her Bachelor of Science in Management degree, Christina obtained an MBA in Pharmaceutical Business and multiple research certifications. Christina strives to bring life-changing therapies to patients faster.